BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27846200)

  • 1. The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.
    Mandilaras V; Bouganim N; Yin H; Asselah J; Azoulay L
    Br J Cancer; 2017 Jan; 116(1):103-108. PubMed ID: 27846200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term use of angiotensin receptor blockers and the risk of cancer.
    Azoulay L; Assimes TL; Yin H; Bartels DB; Schiffrin EL; Suissa S
    PLoS One; 2012; 7(12):e50893. PubMed ID: 23251399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study.
    Hallas J; Christensen R; Andersen M; Friis S; Bjerrum L
    Br J Clin Pharmacol; 2012 Jul; 74(1):180-8. PubMed ID: 22243442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs).
    Hsieh MS; How CK; Hsieh VC; Chen PC
    Shock; 2020 Apr; 53(4):407-415. PubMed ID: 31135703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
    Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis.
    Zhuang S; Wang HF; Li J; Wang HY; Wang X; Xing CM
    Neurosci Lett; 2016 Jun; 624():53-61. PubMed ID: 27163195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis.
    Dial S; Nessim SJ; Kezouh A; Benisty J; Suissa S
    Br J Clin Pharmacol; 2014 Nov; 78(5):1151-8. PubMed ID: 24803383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
    Mamdani M; Gomes T; Greaves S; Manji S; Juurlink DN; Tadrous M; Kennedy SH; Antoniou T
    JAMA Netw Open; 2019 Oct; 2(10):e1913304. PubMed ID: 31617924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
    Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
    Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
    Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
    J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
    Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
    Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension.
    Graham DJ; Izurieta HS; Muthuri SG; Zhang D; Sandhu AT; Lu Y; Zhao Y; Feng Y; Eworuke E; Lyu H; Gandotra C; Smith ER; Avagyan A; Wernecke M; Kelman JA; Forshee RA; MaCurdy TE
    J Gen Intern Med; 2021 Dec; 36(12):3802-3809. PubMed ID: 34599472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
    Haroon S; Subramanian A; Cooper J; Anand A; Gokhale K; Byne N; Dhalla S; Acosta-Mena D; Taverner T; Okoth K; Wang J; Chandan JS; Sainsbury C; Zemedikun DT; Thomas GN; Parekh D; Marshall T; Sapey E; Adderley NJ; Nirantharakumar K
    BMC Infect Dis; 2021 Mar; 21(1):262. PubMed ID: 33722197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study.
    Hicks BM; Filion KB; Yin H; Sakr L; Udell JA; Azoulay L
    BMJ; 2018 Oct; 363():k4209. PubMed ID: 30355745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
    Marott SC; Nielsen SF; Benn M; Nordestgaard BG
    Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
    Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
    Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.
    Makar GA; Holmes JH; Yang YX
    J Natl Cancer Inst; 2014 Feb; 106(2):djt374. PubMed ID: 24431411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.